SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-129602
Filing Date
2022-12-22
Accepted
2022-12-22 17:20:41
Documents
6
Effectiveness Date
2022-12-22

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2233116d1_s8.htm S-8 77026
2 EXHIBIT 5.1 tm2233116d1_ex5-1.htm EX-5.1 6479
3 EXHIBIT 23.2 tm2233116d1_ex23-2.htm EX-23.2 2115
4 EXHIBIT 23.3 tm2233116d1_ex23-3.htm EX-23.3 14845
5 EXHIBIT 99.2 tm2233116d1_ex99-2.htm EX-99.2 28585
6 EX-FILING FEES tm2233116d1_ex-filingfees.htm EX-FILING FEES 23898
  Complete submission text file 0001104659-22-129602.txt   154071
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268965 | Film No.: 221482786
SIC: 2836 Biological Products, (No Diagnostic Substances)